Clinical trial
Clinical Evaluation of the Nova Max Pro Statsensor Point of Care Creatinine Measuring Device in the Clinical Outpatient and Home Setting & Assessment of the Patient Experience
NCT07392710 is registered in ClinicalTrials.gov with Royal Free Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Nova Max Pro Statsensor Point of Care Creatinine Measuring Device in the Clinical Outpatient and Home Setting & Assessment of the Patient Experience
- Lead sponsor
- Royal Free Hospital NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 2, 2023
- Completion date
- December 12, 2024
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney disease, chronic, kidney transplant